跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

本页为预印本版本;arXiv 收录、作者填写的期刊信息以及作者既有发表经历,都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对,只展示已核实例,档案仍可能误合并。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要直接研究治疗效应的人群迁移及正值性违反,属于因果推断。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Paul N Zivich
Jessie K Edwards
Bonnie E Shook-Sa
Eric T Lofgren
Justin Lessler
Stephen R Cole

连续协变量下应对正值性违反的综合估计量

研究问题
将试验中的治疗效应推广至目标人群时,若连续协变量的部分取值缺乏试验覆盖,如何处理由此产生的正值性违反?
方法与思路
作者结合统计模型与数学模型整合多来源信息,将既有综合方法扩展至连续协变量,并提出两个增广逆概率加权估计量。
材料陈述的贡献
摘要称,该研究扩展了此前仅针对单一二元协变量的方法,并通过模拟及女性艾滋病患者的抗逆转录病毒治疗实例比较不同方案。
阅读关注点
应核对覆盖不足区域的效应如何由数学模型提供、各数据来源如何衔接,以及估计与不确定性量化依赖哪些额外假设。
阅读边界
这是 arXiv 预印本,不能据此确认同行评审或期刊接收。摘要未说明外推模型的识别条件、误设敏感性或模拟比较的具体结果。

原文摘要

Studies intended to estimate the effect of a treatment, like randomized trials, may not be sampled from the desired target population. To correct for this discrepancy, estimates can be transported to the target population. Methods for transporting between populations are often premised on a positivity assumption, such that all relevant covariate patterns in one population are also present in the other. However, eligibility criteria, particularly in the case of trials, can result in violations of positivity when transporting to external populations. To address nonpositivity, a synthesis of statistical and mathematical models can be considered. This approach integrates multiple data sources (e.g. trials, observational, pharmacokinetic studies) to estimate treatment effects, leveraging mathematical models to handle positivity violations. This approach was previously demonstrated for positivity violations by a single binary covariate. Here, we extend the synthesis approach for positivity violations with a continuous covariate. For estimation, two novel augmented inverse probability weighting estimators are proposed. Both estimators are contrasted with other common approaches for addressing nonpositivity. Empirical performance is compared via Monte Carlo simulation. Finally, the competing approaches are illustrated with an example in the context of two-drug versus one-drug antiretroviral therapy on CD4 T cell counts among women with HIV.

笔记与分组